1-3 of 3
Usha Sitaram
Close
Sort by
Journal Articles

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Clinical Trials & Observations
Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George, Auro Viswabandya, Aby Abraham, Rayaz Ahmed, Ansu Abu Alex, Saravanan Ganesan, Kavitha M. Lakshmi, Usha Sitaram, Sukesh Chandran Nair, Mammen Chandy, Nancy Beryl Janet, Vivi M. Srivastava, Alok Srivastava, Vikram Mathews
Journal: Blood
Blood (2012) 119 (15): 3413–3419.
https://doi.org/10.1182/blood-2011-11-393264
Published: 2012
Includes: Supplemental data
Journal Articles

Identifying Myelodysplastic Syndrome Among Patients with Anemia: Neutrophil Characteristics Computed by a Cell Counter (Beckman Coulter LH750), An Effective Screening Tool

Arpana Palle, MD, Josephine Thomas, DMLT, Usha Sitaram, MBBS, Vandana Kamath, MD, Joy J Mammen, MD, Sukesh C Nair, MD
Journal: Blood
Blood (2011) 118 (21): 5027.
https://doi.org/10.1182/blood.V118.21.5027.5027
Published: 2011
Journal Articles

Impact of Additional Cytogenetic Changes and FLT3 Mutations on the Outcome of Patients with Newly Diagnosed Acute Promyelocytic Leukaemia Treated with Single Agent Arsenic Trioxide.

Vikram Mathews, MD, Maria Thomas, MD, Vivi M. Srivastava, MD, Ezhilarasi Chendamarai, Biju George, MD, Kavitha M. Lakshmi, Auro Viswabandya, MD, Usha Sitaram, MD, Mammen Chandy, MD, Alok Srivastava, MD
Journal: Blood
Blood (2006) 108 (11): 2346.
https://doi.org/10.1182/blood.V108.11.2346.2346
Published: 2006